BG Medicine Reports Third Quarter 2015 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech selloff pulls Wall Street to two-week lows as oil and yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
BG Medicine (BGMD) Reports Q3 Loss of $0.27/Share
November 17, 2015 7:52 AM ESTBG Medicine (: BGMD) reported Q3 EPS of ($0.27), versus ($0.28) reported last year. Revenue for the quarter came in at $334 million, versus $695 million reported last year.
Our operating results in the third quarter of 2015 reflect our ongoing efforts to extend our cash runway through the... More
